enVVeno Medical Corp (NASDAQ:NVNO) — Market Cap & Net Worth
Market Cap & Net Worth: enVVeno Medical Corp (NVNO)
enVVeno Medical Corp (NASDAQ:NVNO) has a market capitalization of $6.11 Million ($6.11 Million) as of August 3, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #28158 globally and #5720 in its home market, demonstrating a 4.85% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying enVVeno Medical Corp's stock price $10.60 by its total outstanding shares 655000 (655.00K). See enVVeno Medical Corp capital reinvestment ratio to understand how much of operating cash flow is reinvested back into capital assets.
enVVeno Medical Corp Market Cap History: 2018 to 2026
enVVeno Medical Corp's market capitalization history from 2018 to 2026. Data shows change from $24.15 Million to $6.94 Million (-26.48% CAGR).
Index Memberships
enVVeno Medical Corp is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.46 Trillion | 0.00% | #816 of 976 |
|
NASDAQ Composite
IXIC
|
$40.26 Trillion | 0.00% | #2609 of 3165 |
Weight: enVVeno Medical Corp's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
enVVeno Medical Corp Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how enVVeno Medical Corp's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
288.26x
enVVeno Medical Corp's market cap is 288.26 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2018 | $24.15 Million | $186.55K | -$13.04 Million | 129.47x | N/A |
| 2019 | $9.01 Million | $31.24K | -$7.63 Million | 288.26x | N/A |
Competitor Companies of NVNO by Market Capitalization
Companies near enVVeno Medical Corp in the global market cap rankings as of August 3, 2026.
Key companies related to enVVeno Medical Corp by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #114 globally with a market cap of $183.80 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #189 globally with a market cap of $124.64 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #233 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
- Medtronic PLC (NYSE:MDT): Ranked #238 globally with a market cap of $103.60 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #114 | Abbott Laboratories | NYSE:ABT | $183.80 Billion | $105.70 |
| #189 | Stryker Corporation | NYSE:SYK | $124.64 Billion | $325.70 |
| #233 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
| #238 | Medtronic PLC | NYSE:MDT | $103.60 Billion | $85.39 |
enVVeno Medical Corp Historical Marketcap From 2018 to 2026
Between 2018 and today, enVVeno Medical Corp's market cap moved from $24.15 Million to $ 6.94 Million, with a yearly change of -26.48%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $6.94 Million | +3204.24% |
| 2025 | $210.12K | -89.38% |
| 2024 | $1.98 Million | -41.25% |
| 2023 | $3.37 Million | +0.78% |
| 2022 | $3.34 Million | -22.61% |
| 2021 | $4.32 Million | -23.82% |
| 2020 | $5.67 Million | -37.09% |
| 2019 | $9.01 Million | -62.71% |
| 2018 | $24.15 Million | -- |
End of Day Market Cap According to Different Sources
On Aug 2nd, 2026 the market cap of enVVeno Medical Corp was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $6.11 Million USD |
| MoneyControl | $6.11 Million USD |
| MarketWatch | $6.11 Million USD |
| marketcap.company | $6.11 Million USD |
| Reuters | $6.11 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About enVVeno Medical Corp
enVVeno Medical Corporation, a clinical-stage medical device company, focuses on the development of bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous disease. The company's lead product is the VenoValve, a replacement venous valve for the treatment of venous chronic venous insufficiency. Its VenoValve implanted into the femoral vein of the patient in … Read more